stage iva hypopharyngeal carcinoma ajcc v8

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous

Suspended
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +17 more
  • Gilbert, Arizona
  • +19 more
Dec 31, 2022

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Squamous Cell Carcinoma,

Active, not recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +19 more
  • Cetuximab
  • +5 more
  • Birmingham, Alabama
  • +255 more
Dec 30, 2022

Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

Recruiting
  • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +28 more
  • San Francisco, California
    University of California, San Francisco
Dec 16, 2022

Blood Tests and Questionnaires in Studying Adherence to

Recruiting
  • Carcinoma of Unknown Primary
  • +30 more
  • Biospecimen Collection
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +24 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 6, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +23 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
  • +1 more
Jul 7, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022